Conditionally replicating adenoviruses for cancer treatment.
about
Adenoviral delivery of pan-caspase inhibitor p35 enhances bystander killing by P450 gene-directed enzyme prodrug therapy using cyclophosphamide+Adenoviral vectors for prodrug activation-based gene therapy for cancerING proteins as potential anticancer drug targets.Molecular imaging of biological gene delivery vehicles for targeted cancer therapy: beyond viral vectors.Dissecting the roles of E1A and E1B in adenoviral replication and RCAd-enhanced RDAd transduction efficacy on tumor cellsTreatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF.Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.Abrogation of estrogen receptor signaling augments cytotoxicity of anticancer drugs on CaSki cervical cancer cells.An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector.Human telomerase reverse transcriptase promoter-driven oncolytic adenovirus with E1B-19 kDa and E1B-55 kDa gene deletionsCombining conditionally replicating adenovirus-mediated gene therapy with chemotherapy: a novel antitumor approach.Application of conditionally replicating adenoviruses in tumor early diagnosis technology, gene-radiation therapy and chemotherapy.Efficient lung orthotopic tumor-growth suppression of oncolytic adenovirus complexed with RGD-targeted bioreducible polymer.Conditionally replicative adenovirus-based mda-7/IL-24 expression enhances sensitivity of colon cancer cells to 5-fluorouracil and doxorubicin.Viral gene therapy for breast cancer: progress and challenges.Assessment of an altered E1B promoter on the specificity and potency of triple-regulated conditionally replicating adenoviruses: implications for the generation of ideal m-CRAs.Dual E1A oncolytic adenovirus: targeting tumor heterogeneity with two independent cancer-specific promoter elements, DF3/MUC1 and hTERT.p53-dependent antiviral RNA-interference facilitates tumor-selective viral replication.Adenovirus-based virotherapy enabled by cellular YB-1 expression in vitro and in vivo.Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA.A combinatory use of adenoviruses expressing melanoma differentiation-associated gene-7 and replication-competent adenoviruses produces synergistic effects on pancreatic carcinoma cells.Targeting strategies of adenovirus‑mediated gene therapy and virotherapy for prostate cancer (Review).
P2860
Q21261309-392E8FC3-0B8E-4193-98C1-5FF83ED700E7Q26860729-534759BF-6334-4298-8CF2-5922B33F45E0Q33574029-09C11188-B76D-41FC-B6CA-BD2AD3ACD4BAQ33704231-789D7CE1-8800-4FB5-BD0A-2B68CF3913A9Q34036114-5B9627B8-CC36-4107-938F-43D96670101EQ34183436-D78DF53F-3801-4CB9-85B6-4E8D9F4C3C6FQ35624010-BA1184AC-E587-4532-9F58-460CAB1EE7C0Q35770309-ABA2BE3A-3940-4646-8D2E-72177952141CQ36209165-23EFABFB-3235-499F-9891-D129A3E7597CQ37274247-EAEA8F48-6B49-46CE-BCF8-E4E9FC113885Q37867584-EC667641-C4F1-41BB-B79C-00CE27C4644AQ38828208-B37EC57E-9508-4646-B0D4-0EE3498CB235Q39018330-69F648AE-8274-4C3F-ACF0-8B0DD29923B1Q39310354-E3FAC6B0-3C17-4AF8-9E12-3ABED398CE48Q39366114-178FFA3B-5303-4773-9EC8-46E0F5911EA0Q39491372-8DB7BB48-D40B-4FD4-8C38-B3577B350DBCQ39652106-456B0289-7B7B-4347-BDC9-C58FAD969442Q39851291-D1434227-D7DA-4730-812A-A298FFF3D23FQ39861470-774EEA7C-C274-4CA0-AC8F-94E3918E4B97Q39952467-FCF7775A-ADAF-47D5-AB30-E7B676B74DA6Q40922871-3FB1A886-E60E-42AA-B8C7-1B7D6C822019Q45871873-F879E83C-08E3-4328-813C-CA95E1460AA4
P2860
Conditionally replicating adenoviruses for cancer treatment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Conditionally replicating adenoviruses for cancer treatment.
@ast
Conditionally replicating adenoviruses for cancer treatment.
@en
type
label
Conditionally replicating adenoviruses for cancer treatment.
@ast
Conditionally replicating adenoviruses for cancer treatment.
@en
prefLabel
Conditionally replicating adenoviruses for cancer treatment.
@ast
Conditionally replicating adenoviruses for cancer treatment.
@en
P2860
P1476
Conditionally replicating adenoviruses for cancer treatment
@en
P2093
Youssef Jounaidi
P2860
P304
P356
10.2174/156800907780618301
P577
2007-05-01T00:00:00Z